Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

IPF Partners

Investor type Venture Debt


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 22
Average round size
The average size of a deal this fund participated in
Portfolio companies 15
Rounds per year 2.00
Lead investments 6
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 7
Key employees 7

Areas of investment

  • Health Care
  • Hospital
  • Medical Device
  • Medical
  • Information Technology

IPF Partners is the famous VC, which was founded in 2011. The company was established in Europe in Luxembourg. The main office of represented VC is situated in the Luxembourg.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the IPF Partners, startups are often financed by Seventure Partners, HealthCap, Fountain Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Fraser Finance, Whiz Partners, Reaktor Ventures. In the next rounds fund is usually obtained by KCK, Third Swedish National Pension Fund, The Cedars-Sinai Accelerator.

We also calculated 4 valuable employees in our database.

Among the most popular fund investment industries, there are Analytics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Lumeon, EOS Imaging, Impeto Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 11-15 years to get the investment from the fund.

The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. This IPF Partners works on 9 percentage points more the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 24 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2017.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of IPF Partners:
Typical Co-investors
IPF Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after IPF Partners:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Assets New Ventures -
Chartwell Investments New York, New York, United States
Chiesi Ventures Boston, Massachusetts, United States
China Asset Management Beijing, Beijing, China
Clarsia investments -
Group8 - Beijing, Beijing, China
NewSpring Ventures Pennsylvania, Radnor, United States
Pepper Media Holding Berlin, Berlin, Germany
Puget Sound Venture Club Bellevue, United States, Washington
Shanghai Furong Investment China, Shanghai
Sparbanksstiftelse Norrlands Riskkapitalstiftelse -
Sprout Capital Bangalore, India, Karnataka
Suzhou Decheng Hongxing Touzi China, Jiangsu, Suzhou
Taiheng Touzi China, Hangzhou, Zhejiang
The James Irvine Foundation California, San Francisco, United States
The Phoenix Fund Delhi, India, New Delhi
Verve Capital Florida, Miami, United States
Zero Gravity Lisboa, Lisbon, Portugal
Zhejiang Wanghe Touzi Guanli Gufen Youxian Gongsi China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Faron Pharmaceuticals

$30M28 Feb 2022 Turku, Southwest Finland, Finland


Artificial Intelligence
Data Visualization
Health Care
Health Insurance
Information Technology
Machine Learning
$130M16 Sep 2021 Boston, Massachusetts, United States


Health Care
Health Insurance
Information Technology
Machine Learning
$100M28 Apr 2021 Boston, Massachusetts, United States


Health Care
$30M11 Aug 2020 London, England, United Kingdom


Health Care
Health Insurance
Information Technology
Machine Learning
$45M12 Dec 2019 Boston, Massachusetts, United States


Health Care
$28M04 Dec 2018 London, England, United Kingdom


Health Care
Information Technology
Medical Device
$10M13 Sep 2018 France, Ile-de-France, France

Genesis Automation

Industrial Automation
$24M21 Jan 2018 Saint Charles, Illinois, United States


Health Care
$8M01 Jun 2017 London, England, United Kingdom
Caresyntax Grabs $30M Series C Extension

– Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced a $30m extension to its Series C funding round.
– The round was led by PFM Health Sciences with participation from ProAssurance, Harmonix, and existing investors such as the Relyens Group and IPF Partners.
– That round also included investments from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, and Surgical.AI.
– The funding will be used to continue developing its platform as well as advance new data solutions that support value-based care providers.

Caresyntax Raises $100M in Series C Funding

– Caresyntax from Boston is a digital surgery platform that provides actionable insights to improve patient outcomes.
– The company closed a $100m Series C funding.
– The round was led by PFM Health Sciences LP and included participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, as well as current investors IPF Partners, the Relyens Group, and Surgical.
– The new investment will be used to accelerate the company’s global expansion and development of new products.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IPF Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: